{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:37:39Z","timestamp":1787564259918,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003549","name":"Hungarian Scientific Research Fund","doi-asserted-by":"publisher","award":["2022-2.1.1-NL-2022-00010"],"award-info":[{"award-number":["2022-2.1.1-NL-2022-00010"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Oncology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although a\u00a0cornerstone of modern cancer treatment, radiotherapy (RT) is associated with a risk of secondary cancer due to irradiation of non-target tissues. Techniques such as intensity-modulated RT (IMRT), volumetric modulated RT (VMAT), and stereotactic body RT (SBRT) provide highly conformal target dose distributions and reduce doses to nearby organs at risk (OARs), albeit at the cost of larger normal tissue volumes being irradiated with lower doses. In brachytherapy (BT), the low-value isodoses cannot be changed: they are a consequence of the inverse-square law. This study evaluates and compares the normal tissue integral doses (NTIDs) delivered by BT and modern external-beam RT (EBRT) techniques in breast and head and neck (H&amp;N) cancer patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Included were the BT and IMRT plans of 34\u00a0women with early-stage breast cancer treated with interstitial high-dose-rate (HDR) BT and two groups of head and neck (H&amp;N) patients: 38\u00a0patients with mobile tongue, floor of the mouth, and base of the tongue cancer treated definitively with interstitial HDR BT for whom VMAT treatment plans were also prepared and 20\u00a0patients with tongue and floor of the mouth tumors who received postoperative interstitial HDR BT for whom VMAT and stereotactic CyberKnife (CK,\u00a0Accuray Inc., Sunnyvale, CA, USA) plans were also created. The NTIDs for three normal tissue volumes (NT_V10, NT_V5, NT_V2) and OARs were calculated and compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Brachytherapy resulted in 39%, 32%, and 26% lower NTIDs compared to IMRT for NT_V10, NT_V5, and NT_V2, respectively, in patients with breast cancer. In H&amp;N cancer, the NTIDs were always lower for BT compared to VMAT. The reductions in NTID achieved with BT were 45%, 36% and 27% with the same planning target volumes in BT and VMAT, and 56%, 48% and 37% with larger planning target volumes in VMAT. For CK, the NTID reductions were 54%, 49% and 41% compared to BT. In breast cases, BT resulted in a significant reduction in ipsilateral lung NTID, and in H&amp;N cases, salivary glands NTIDs were always lower with BT than with VMAT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>For patients with breast and head and neck cancer, interstitial BT results in lower integral dose to normal tissue and OARs compared to modern EBRT techniques. The clinical implications require further detailed investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00066-025-02382-3","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T07:00:26Z","timestamp":1742194826000},"page":"30-39","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of integral doses to normal tissue and organs at risk between interstitial high-dose-rate brachytherapy and modern external-beam radiotherapy techniques in breast and head and neck cancer patients"],"prefix":"10.1007","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4672-6910","authenticated-orcid":false,"given":"Tibor","family":"Major","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7245-0762","authenticated-orcid":false,"given":"Csaba","family":"Polg\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3261-0271","authenticated-orcid":false,"given":"Zolt\u00e1n","family":"Tak\u00e1csi-Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"2382_CR1","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.ijrobp.2007.10.034","volume":"70","author":"F Nguyen","year":"2008","unstructured":"Nguyen\u00a0F, Rubino\u00a0C, Guerin\u00a0S et\u00a0al (2008) Risk of a\u00a0second malignant neoplasm after cancer in childhood treated with radiotherapy: Correlation with the integral dose restricted to the irradiated fields. Int J Radiat Oncol Biol Phys 70:908\u2013915. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.10.034","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2382_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0360-3016(03)00073-7","volume":"56","author":"EJ Hall","year":"2003","unstructured":"Hall\u00a0EJ, Wuu\u00a0CS (2003) Radiation-induced second cancers: The impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 56:83\u201388. https:\/\/doi.org\/10.1016\/S0360-3016(03)00073-7","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2382_CR3","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.adro.2019.07.010","volume":"4","author":"AL Holtzman","year":"2019","unstructured":"Holtzman\u00a0AL, Stahl\u00a0JM, Zhu\u00a0S et\u00a0al (2019) Does the Incidence of Treatment-Related Toxicity Plateau After Radiation Therapy: The Long-Term Impact of Integral Dose in Hodgkin\u2019s Lymphoma Survivors. Advan Radiat Oncol 4:699\u2013705. https:\/\/doi.org\/10.1016\/j.adro.2019.07.010","journal-title":"Advan Radiat Oncol"},{"key":"2382_CR4","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1118\/1.1591991","volume":"30","author":"WR D\u2019Souza II","year":"2003","unstructured":"D\u2019Souza\u00a0WR II (2003) Nontumor integral dose variation in conventional radiotherapy treatment planning. Medl Phys 30:2065\u20132071. https:\/\/doi.org\/10.1118\/1.1591991","journal-title":"Medl Phys"},{"issue":"3","key":"2382_CR5","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.meddos.2007.11.001","volume":"33","author":"C Shi","year":"2008","unstructured":"Shi\u00a0C, Penagaricano\u00a0J, Papanikolau\u00a0N (2008) Comparison of IMRT treatment plans between linac and Helical Tomotherapy based on integral dose and inhomogeneity index. Med Dosim 33(3):215\u2013221. https:\/\/doi.org\/10.1016\/j.meddos.2007.11.001","journal-title":"Med Dosim"},{"key":"2382_CR6","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.clon.2009.08.002","volume":"21","author":"R Yang","year":"2009","unstructured":"Yang\u00a0R, Xuy\u00a0S, Jiang\u00a0W et\u00a0al (2009) Integral Dose in Three-dimensional Conformal Radiotherapy, Intensity-modulated Radiotherapy and Helical Tomotherapy. Clin Oncol 21:706\u2013712. https:\/\/doi.org\/10.1016\/j.clon.2009.08.002","journal-title":"Clin Oncol"},{"key":"2382_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.rpor.2014.10.010","volume":"20","author":"K \u015alosarek","year":"2014","unstructured":"\u015alosarek\u00a0K, Osewski\u00a0W, Grz\u0105dziel\u00a0A et\u00a0al (2014) Integral dose: Comparison between four techniques for prostate radiotherapy. Rep Pract Oncol Radiother 20:99\u2013103. https:\/\/doi.org\/10.1016\/j.rpor.2014.10.010","journal-title":"Rep Pract Oncol Radiother"},{"issue":"2","key":"2382_CR8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jmir.2014.11.003","volume":"46","author":"S Patel","year":"2015","unstructured":"Patel\u00a0S, Drodge\u00a0S, Jacques\u00a0A et\u00a0al (2015) A comparative planning analysis and integral dose of Volumetric Modulated Arc Therapy, Helical Tomotherapy, and Three-dimensional Conformal Craniospinal Irradiation for pediatric medulloblastoma. J\u00a0Med Imaging Radiat Sci 46(2):134\u2013140. https:\/\/doi.org\/10.1016\/j.jmir.2014.11.003","journal-title":"J Med Imaging Radiat Sci"},{"issue":"3","key":"2382_CR9","doi-asserted-by":"publisher","first-page":"101160","DOI":"10.1016\/j.adro.2022.101160","volume":"8","author":"VP Grzywacz","year":"2022","unstructured":"Grzywacz\u00a0VP, Arden\u00a0JD, Mankuzhy\u00a0NP et\u00a0al (2022) Normal Tissue Integral Dose as a\u00a0Result of Prostate Radiation Therapy: A\u00a0Quantitative Comparison Between High-Dose-Rate Brachytherapy and Modern External Beam Radiation Therapy Techniques. Adv Radiat Oncol 8(3):101160. https:\/\/doi.org\/10.1016\/j.adro.2022.101160","journal-title":"Adv Radiat Oncol"},{"issue":"2","key":"2382_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4103\/0971-6203.79687","volume":"36","author":"B Shwetha","year":"2011","unstructured":"Shwetha\u00a0B, Ravikumar\u00a0M, Palled\u00a0SR et\u00a0al (2011) Dosimetric comparison of high dose rate brachytherapy and intensity-modulated radiation therapy for cervical carcinoma. J\u00a0Med Phys 36(2):111\u2013116. https:\/\/doi.org\/10.4103\/0971-6203.79687","journal-title":"J Med Phys"},{"key":"2382_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00066-008-1684-y","volume":"184","author":"J Richert","year":"2008","unstructured":"Richert\u00a0J, Baier\u00a0K, Flentje\u00a0M (2008) Comparison of 60Cobalt and 192Iridium Sources in High Dose Rate Afterloading Brachytherapy. Strahlenther Onkol 184:187\u2013192. https:\/\/doi.org\/10.1007\/s00066-008-1684-y","journal-title":"Strahlenther Onkol"},{"key":"2382_CR12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4103\/jcrt.JCRT_199_19","volume":"17","author":"S Yadav","year":"2021","unstructured":"Yadav\u00a0S, Singh\u00a0OP, Choudhary\u00a0S et\u00a0al (2021) Estimation and comparison of integral dose to target and organs at risk in three-dimensional computed tomography image-based treatment planning of carcinoma uterine cervix with two high-dose-rate brachytherapy sources: 60Co and 192Ir. J\u00a0Can Res Ther 17:191\u2013197. https:\/\/doi.org\/10.4103\/jcrt.JCRT_199_19","journal-title":"J Can Res Ther"},{"key":"2382_CR13","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s00066-023-02181-8","volume":"200","author":"MC Brekner","year":"2024","unstructured":"Brekner\u00a0MC, Imhoff\u00a0D, R\u00f6del\u00a0C et\u00a0al (2024) Stereotactic body radiotherapy with volumetric intensity-modulated arc therapy and flattening filter-free beams: dosimetric considerations. Strahlenther Onkol 200:346\u2013357. https:\/\/doi.org\/10.1007\/s00066-023-02181-8","journal-title":"Strahlenther Onkol"},{"key":"2382_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.radonc.2016.08.003","volume":"22","author":"T Major","year":"2017","unstructured":"Major\u00a0T, Stelczer\u00a0G, Peszny\u00e1k\u00a0C et\u00a0al (2017) Multicatheter interstitial brachytherapy versus intensity modulated external beam therapy for accelerated partial breast irradiation: A\u00a0comparative treatment planning study with respect to dosimetry of organs at risk. Radiother Oncol 22:17\u201323. https:\/\/doi.org\/10.1016\/j.radonc.2016.08.003","journal-title":"Radiother Oncol"},{"key":"2382_CR15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.2478\/raon-2018-0042","volume":"52","author":"H Akiyama","year":"2018","unstructured":"Akiyama\u00a0H, Peszny\u00e1k Cs\u00a0BD et\u00a0al (2018) Image guided high-dose-rate brachytherapy versus volumetric modulated arc therapy for head and neck cancer: A\u00a0comparative analysis of dosimetry for target volume and organs at risk. Radiol Oncol 52:461\u2013467. https:\/\/doi.org\/10.2478\/raon-2018-0042","journal-title":"Radiol Oncol"},{"key":"2382_CR16","doi-asserted-by":"publisher","first-page":"516","DOI":"10.2478\/raon-2023-0050","volume":"57","author":"\u00d6 Ferenczi","year":"2023","unstructured":"Ferenczi \u00d6, Major\u00a0T, Fr\u00f6hlich\u00a0G et\u00a0al (2023) Dosimetric comparison of postoperative interstitial high-dose-rate brachytherapy and modern external beam radiotherapy modalities in tongue and floor of the mouth tumours in terms of doses to critical organs. Radiol Oncol 57:516\u2013523. https:\/\/doi.org\/10.2478\/raon-2023-0050","journal-title":"Radiol Oncol"},{"key":"2382_CR17","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.ijrobp.2005.11.005","volume":"64","author":"H Aoyama","year":"2006","unstructured":"Aoyama\u00a0H, Westerly\u00a0DC, Mackie\u00a0TR et\u00a0al (2006) Integral radiation dose to normal structures with conformal external beam radiation. Int J Radiat Oncol Biol Phys 64:962\u2013967. https:\/\/doi.org\/10.1016\/j.ijrobp.2005.11.005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2382_CR18","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.3390\/ijerph9114223","volume":"9","author":"M D\u2019Arienzo","year":"2012","unstructured":"D\u2019Arienzo\u00a0M, Masciullo\u00a0SG, de Sanctis\u00a0V et\u00a0al (2012) Integral dose and radiation-induced cecondary malignancies: comparison between stereotactic body radiation therapy and three-dimensional conformal radiotherapy. Int J Environ Res Public Health 9:4223\u20134240. https:\/\/doi.org\/10.3390\/ijerph9114223","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"2382_CR19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s13246-015-0341-x","volume":"38","author":"C Fox","year":"2015","unstructured":"Fox\u00a0C, Hardcastle\u00a0N, Lim\u00a0A et\u00a0al (2015) Calculating integral dose using data exported from a\u00a0commercial record and verify system. Australas Phys Eng Sci Med 38(2):283\u2013288. https:\/\/doi.org\/10.1007\/s13246-015-0341-x","journal-title":"Australas Phys Eng Sci Med"},{"key":"2382_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/s0167-8140(86)80051-2","volume":"5","author":"J Roth","year":"1986","unstructured":"Roth\u00a0J, H\u00fcnig\u00a0R, Kurtz\u00a0J (1986) Specific integral dose: A\u00a0reconsideration of the integral dose conceptSpecific integral dose: A\u00a0reconsideration of the integral dose concept. Radiother Oncol 5:215\u2013221. https:\/\/doi.org\/10.1016\/s0167-8140(86)80051-2","journal-title":"Radiother Oncol"},{"issue":"2","key":"2382_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00066-021-01867-1","volume":"198","author":"T Major","year":"2022","unstructured":"Major\u00a0T, Fr\u00f6hlich\u00a0G, \u00c1goston\u00a0P et\u00a0al (2022) The value of brachytherapy in the age of advanced external beam radiotherapy: a\u00a0review of the literature in terms of dosimetry. Strahlenther Onkol 198(2):93\u2013109. https:\/\/doi.org\/10.1007\/s00066-021-01867-1","journal-title":"Strahlenther Onkol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-025-02382-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-025-02382-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-025-02382-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T13:18:44Z","timestamp":1768915124000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-025-02382-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2382"],"URL":"https:\/\/doi.org\/10.1007\/s00066-025-02382-3","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"4 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.\u00a0Major, C.\u00a0Polg\u00e1r, and Z.\u00a0Tak\u00e1csi-Nagy declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}